The effect of transforming solution (RTS) on CML (K562) shows that RTS can induce autophagy with CML cells at a lower arsenic level by up‐regulating LC3, p62/SQSTM1 and mTOR inhibition, suggesting that autophagy can be a novel measure for CML therapy (Wang et al., 2018). Here, MAP1LC3A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.